Lourdes Ramírez-Orrego, Luis M. Rojas, Christian J. Campos, Carmen Gutierrez, Stella M. Chenet, Lizandro Gonzales
{"title":"2021年和2022年秘鲁亚马逊州巴尔萨斯首次报告登革热疫情。","authors":"Lourdes Ramírez-Orrego, Luis M. Rojas, Christian J. Campos, Carmen Gutierrez, Stella M. Chenet, Lizandro Gonzales","doi":"10.25176/rfmh.v23i3.5846","DOIUrl":null,"url":null,"abstract":"Introduction: The increase in dengue cases in Amazonas is a risk to public health. In 2021, Balsas reported a dengue outbreak for the first time. Methodology: The population included patients who met the case definition between December 2021 and February 2022. Identification of serotypes will be reduced by multiplex qRT-PCR. Results: 72 patients were identified, of which 53 (74%) were confirmed by serology (Ag NS1). The predominant serotype was DENV-2 (94%), and 6% was DENV-1. Patients between 19 and 45 years old presented the highest percentage of cases (59%). The most frequent symptoms were fever, headache, myalgia and arthralgia; 23% presented severe abdominal pain. Conclusion: This was the first confirmed dengue outbreak in the Balsas district, with DENV-2 being the main cause of the outbreak, highlighting the need to improve surveillance in areas without autochthonous transmission of the disease.","PeriodicalId":33139,"journal":{"name":"Revista de la Facultad de Medicina Humana","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First report of a Dengue outbreak in Balsas, Amazonas, Peru, during 2021 and 2022.\",\"authors\":\"Lourdes Ramírez-Orrego, Luis M. Rojas, Christian J. Campos, Carmen Gutierrez, Stella M. Chenet, Lizandro Gonzales\",\"doi\":\"10.25176/rfmh.v23i3.5846\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: The increase in dengue cases in Amazonas is a risk to public health. In 2021, Balsas reported a dengue outbreak for the first time. Methodology: The population included patients who met the case definition between December 2021 and February 2022. Identification of serotypes will be reduced by multiplex qRT-PCR. Results: 72 patients were identified, of which 53 (74%) were confirmed by serology (Ag NS1). The predominant serotype was DENV-2 (94%), and 6% was DENV-1. Patients between 19 and 45 years old presented the highest percentage of cases (59%). The most frequent symptoms were fever, headache, myalgia and arthralgia; 23% presented severe abdominal pain. Conclusion: This was the first confirmed dengue outbreak in the Balsas district, with DENV-2 being the main cause of the outbreak, highlighting the need to improve surveillance in areas without autochthonous transmission of the disease.\",\"PeriodicalId\":33139,\"journal\":{\"name\":\"Revista de la Facultad de Medicina Humana\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de la Facultad de Medicina Humana\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25176/rfmh.v23i3.5846\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de la Facultad de Medicina Humana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25176/rfmh.v23i3.5846","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
First report of a Dengue outbreak in Balsas, Amazonas, Peru, during 2021 and 2022.
Introduction: The increase in dengue cases in Amazonas is a risk to public health. In 2021, Balsas reported a dengue outbreak for the first time. Methodology: The population included patients who met the case definition between December 2021 and February 2022. Identification of serotypes will be reduced by multiplex qRT-PCR. Results: 72 patients were identified, of which 53 (74%) were confirmed by serology (Ag NS1). The predominant serotype was DENV-2 (94%), and 6% was DENV-1. Patients between 19 and 45 years old presented the highest percentage of cases (59%). The most frequent symptoms were fever, headache, myalgia and arthralgia; 23% presented severe abdominal pain. Conclusion: This was the first confirmed dengue outbreak in the Balsas district, with DENV-2 being the main cause of the outbreak, highlighting the need to improve surveillance in areas without autochthonous transmission of the disease.